Delos Reyes, Mark Harvey M.
HRN: 22-35-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
CEFUROXIME 750MG (VIAL)
12/27/2022
01/02/2023
IV
280mg
Q8Hrs
PCAP-C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes